Neurodegeneration in an animal model of Parkinsons disease is exacerbated by a high-fat diet
Now, two new late-phase clinical trials, sponsored by Eli Lilly and Company, suggest that transitioning from high dose injectable weight loss medications to either a daily pill or a lower maintenance dose can help people living with obesity to keep off most of the weight they have already lost The results of the ATTAIN-MAINTAIN and SURMOUNT-MAINTAIN trials were presented at the European Congress on Obesity and published in Previous research suggests that 1 year after stopping weight loss medication, people may regain, on average, 60% of their lost weight
Wegovy European Public Assessment Report
10.1515/BC.2009.033 Biol Chem
In cutaneous melanomas, well-known differences exist in the biologic behaviors of the radial growth phasemelanoma (flat or macular), vertical growth phasemelanoma (mass, nodule, elevation), and vertical growth phasemelanoma with metastasis